344 research outputs found

    Making ERP research more transparent: Guidelines for preregistration

    Get PDF
    A combination of confirmation bias, hindsight bias, and pressure to publish may prompt the (unconscious) exploration of various methodological options and reporting only the ones that lead to a (statistically) significant outcome. This undisclosed analytic flexibility is particularly relevant in EEG research, where a myriad of preprocessing and analysis pipelines can be used to extract information from complex multidimensional data. One solution to limit confirmation and hindsight bias by disclosing analytic choices is preregistration: researchers write a time-stamped, publicly accessible research plan with hypotheses, data collection plan, and the intended preprocessing and statistical analyses before the start of a research project. In this manuscript, we present an overview of the problems associated with undisclosed analytic flexibility, discuss why and how EEG researchers would benefit from adopting preregistration, provide guidelines and examples on how to preregister data preprocessing and analysis steps in typical ERP studies, and conclude by discussing possibilities and limitations of this open science practice

    The Boston University Photonics Center annual report 2016-2017

    Full text link
    This repository item contains an annual report that summarizes activities of the Boston University Photonics Center in the 2016-2017 academic year. The report provides quantitative and descriptive information regarding photonics programs in education, interdisciplinary research, business innovation, and technology development. The Boston University Photonics Center (BUPC) is an interdisciplinary hub for education, research, scholarship, innovation, and technology development associated with practical uses of light.This has undoubtedly been the Photonics Center’s best year since I became Director 10 years ago. In the following pages, you will see highlights of the Center’s activities in the past year, including more than 100 notable scholarly publications in the leading journals in our field, and the attraction of more than 22 million dollars in new research grants/contracts. Last year I had the honor to lead an international search for the first recipient of the Moustakas Endowed Professorship in Optics and Photonics, in collaboration with ECE Department Chair Clem Karl. This professorship honors the Center’s most impactful scholar and one of the Center’s founding visionaries, Professor Theodore Moustakas. We are delighted to haveawarded this professorship to Professor Ji-Xin Cheng, who joined our faculty this year.The past year also marked the launch of Boston University’s Neurophotonics Center, which will be allied closely with the Photonics Center. Leading that Center will be a distinguished new faculty member, Professor David Boas. David and I are together leading a new Neurophotonics NSF Research Traineeship Program that will provide $3M to promote graduate traineeships in this emerging new field. We had a busy summer hosting NSF Sites for Research Experiences for Undergraduates, Research Experiences for Teachers, and the BU Student Satellite Program. As a community, we emphasized the theme of “Optics of Cancer Imaging” at our annual symposium, hosted by Darren Roblyer. We entered a five-year second phase of NSF funding in our Industry/University Collaborative Research Center on Biophotonic Sensors and Systems, which has become the centerpiece of our translational biophotonics program. That I/UCRC continues to focus on advancing the health care and medical device industries

    The Boston University Photonics Center annual report 2014-2015

    Full text link
    This repository item contains an annual report that summarizes activities of the Boston University Photonics Center in the 2014-2015 academic year. The report provides quantitative and descriptive information regarding photonics programs in education, interdisciplinary research, business innovation, and technology development. The Boston University Photonics Center (BUPC) is an interdisciplinary hub for education, research, scholarship, innovation, and technology development associated with practical uses of light.This has been a good year for the Photonics Center. In the following pages, you will see that the center’s faculty received prodigious honors and awards, generated more than 100 notable scholarly publications in the leading journals in our field, and attracted $18.6M in new research grants/contracts. Faculty and staff also expanded their efforts in education and training, and were awarded two new National Science Foundation– sponsored sites for Research Experiences for Undergraduates and for Teachers. As a community, we hosted a compelling series of distinguished invited speakers, and emphasized the theme of Advanced Materials by Design for the 21st Century at our annual symposium. We continued to support the National Photonics Initiative, and are a part of a New York–based consortium that won the competition for a new photonics- themed node in the National Network of Manufacturing Institutes. Highlights of our research achievements for the year include an ambitious new DoD-sponsored grant for Multi-Scale Multi-Disciplinary Modeling of Electronic Materials led by Professor Enrico Bellotti, continued support of our NIH-sponsored Center for Innovation in Point of Care Technologies for the Future of Cancer Care led by Professor Catherine Klapperich, a new award for Personalized Chemotherapy Through Rapid Monitoring with Wearable Optics led by Assistant Professor Darren Roblyer, and a new award from DARPA to conduct research on Calligraphy to Build Tunable Optical Metamaterials led by Professor Dave Bishop. We were also honored to receive an award from the Massachusetts Life Sciences Center to develop a biophotonics laboratory in our Business Innovation Center

    The Boston University Photonics Center annual report 2014-2015

    Full text link
    This repository item contains an annual report that summarizes activities of the Boston University Photonics Center in the 2014-2015 academic year. The report provides quantitative and descriptive information regarding photonics programs in education, interdisciplinary research, business innovation, and technology development. The Boston University Photonics Center (BUPC) is an interdisciplinary hub for education, research, scholarship, innovation, and technology development associated with practical uses of light.This has been a good year for the Photonics Center. In the following pages, you will see that the center’s faculty received prodigious honors and awards, generated more than 100 notable scholarly publications in the leading journals in our field, and attracted $18.6M in new research grants/contracts. Faculty and staff also expanded their efforts in education and training, and were awarded two new National Science Foundation– sponsored sites for Research Experiences for Undergraduates and for Teachers. As a community, we hosted a compelling series of distinguished invited speakers, and emphasized the theme of Advanced Materials by Design for the 21st Century at our annual symposium. We continued to support the National Photonics Initiative, and are a part of a New York–based consortium that won the competition for a new photonics- themed node in the National Network of Manufacturing Institutes. Highlights of our research achievements for the year include an ambitious new DoD-sponsored grant for Multi-Scale Multi-Disciplinary Modeling of Electronic Materials led by Professor Enrico Bellotti, continued support of our NIH-sponsored Center for Innovation in Point of Care Technologies for the Future of Cancer Care led by Professor Catherine Klapperich, a new award for Personalized Chemotherapy Through Rapid Monitoring with Wearable Optics led by Assistant Professor Darren Roblyer, and a new award from DARPA to conduct research on Calligraphy to Build Tunable Optical Metamaterials led by Professor Dave Bishop. We were also honored to receive an award from the Massachusetts Life Sciences Center to develop a biophotonics laboratory in our Business Innovation Center

    Vitamin K and metabolic syndrome: is there a link?

    Get PDF
    Dado que cerca de um quarto da população adulta mundial apresenta síndrome metabólica, encontrar estratégias para atrasar, ou até prevenir, o aparecimento de patologias associadas a esta condição, como doenças cardiovasculares (DCV), a diabetes tipo 2 (DT2) e a obesidade, revela-se fundamental. A síndrome metabólica encontra-se relacionada com a malnutrição e os micronutrientes têm vindo a ganhar relevância como ferramentas terapêuticas nesta condição. Níveis reduzidos das vitaminas lipossolúveis A, D e E parecem estar associados ao desenvolvimento de síndrome metabólica e, nos últimos anos, foi descoberto que a vitamina K não é, apenas, uma vitamina anti-hemorrágica. A vitamina K tem propriedades anti-inflamatórias e antioxidantes e, para além do seu papel na síntese de várias proteínas Gla, parece estar envolvida na regulação de vias moleculares associadas ao metabolismo. A vitamina K pode proteger de diversas patologias, incluindo DCV, osteoporose, obesidade e DT2. Neste trabalho, serão revistas as fontes de vitamina K, o seu metabolismo e biomarcadores, bem como as evidências atuais do efeito das vitaminas K1 e K2 na inflamação, resistência à insulina, obesidade, dislipidemias e hipertensão arterial, e os seus mecanismos subjacentes.With approximately a quarter of the adult population in the world suffering from metabolic syndrome, finding strategies to delay, or even prevent, the development of diseases associated with this condition, such as cardiovascular diseases (CVD), type 2 diabetes (T2D) and obesity, is paramount. Metabolic syndrome is linked to malnutrition and micronutrients have been gaining acceptance as therapeutic tools for this condition. Low levels of the fat-soluble vitamins A, D and E seem to be associated with metabolic syndrome and, in recent years, it was discovered that vitamin K is more than just an antihaemorrhagic vitamin. It has anti-inflammatory and antioxidant properties and, in addition to its role in the synthesis of several Gla proteins, it seems to be involved in the regulation of metabolic pathways associated with metabolism. Vitamin K may protect from several diseases, including CVD, osteoporosis, obesity and T2D. Within this work, we present an overview of vitamin K sources, metabolism and biomarkers, as well as the current available evidence of the effect of vitamins K1 and K2 on inflammation, insulin resistance, obesity, dyslipidemia and high blood pressure, and their underlying mechanisms

    Quantitative imaging in radiation oncology

    Get PDF
    Artificially intelligent eyes, built on machine and deep learning technologies, can empower our capability of analysing patients’ images. By revealing information invisible at our eyes, we can build decision aids that help our clinicians to provide more effective treatment, while reducing side effects. The power of these decision aids is to be based on patient tumour biologically unique properties, referred to as biomarkers. To fully translate this technology into the clinic we need to overcome barriers related to the reliability of image-derived biomarkers, trustiness in AI algorithms and privacy-related issues that hamper the validation of the biomarkers. This thesis developed methodologies to solve the presented issues, defining a road map for the responsible usage of quantitative imaging into the clinic as decision support system for better patient care

    Dynamics of High-Resolution Networks

    Get PDF

    Modeling and prediction of advanced prostate cancer

    Get PDF
    Background: Prostate cancer (PCa) is the most commonly diagnosed cancer and second leading cause of cancer-related deaths for men in Western countries. The advanced form of the disease is life-threatening with few options for curative therapies. The development of novel therapeutic alternatives would greatly benefit from a more comprehensive and tailored mathematical and statistical methodology. In particular, statistical inference of treatment effects and the prediction of time-dependent effects in both preclinical and clinical studies remains a challenging yet interesting opportunity for applied mathematicians. Such methods are likely to improve the reproducibility and translatability of results and offer possibility for novel holistic insights into disease progression, diagnosis, and prognosis. Methods: Several novel statistical and mathematical techniques were developed over the course of this thesis work for the in vivo modeling of PCa treatment responses. A matching-based, blinded randomized allocation procedure for preclinical experiments was developed that provides assistance for the statistical design of animal intervention studies, e.g., through power analysis and accounting for the stratification of individuals. For the post-intervention testing of treatment effects, two novel mixed-effects models were developed that aim to address the characteristic challenges of preclinical longitudinal experiments, including the heterogeneous response profiles observed in animal studies. Subsequently, a Finnish clinical PCa hospital registry cohort was inspected with a strong emphasis on prostate-specific antigen (PSA), the most commonly used PCa marker. After exploring the PSA trends using penalized splines, a generalized mixed-effects prediction model was implemented with a focus on the ultra-sensitive range of the PSA assay. Finally, for metastatic, aggressive PCa, an ensemble Cox regression methodology was developed for overall survival prediction in the DREAM 9.5 mCRPC Challenge based on open datasets from controlled clinical trials. Results: The advantages of the improved experimental design and two proposed statistical models were demonstrated in terms of both increased statistical power and accuracy in simulated and real preclinical testing settings. Penalized regression models applied to the clinical patient datasets support the use of PSA in the ultra-sensitive range together with a model for relapse prediction. Furthermore, the novel ensemble-based Cox regression model that was developed for the overall survival prediction in advanced PCa outperformed the state-of-the-art benchmark and all other models submitted to the Challenge and provided novel predictors of disease progression and treatment responses. Conclusions: The methods and results provide preclinical researchers and clinicians with novel tools for comprehensive modeling and prediction of PCa. All methodology is available as open source R statistical software packages and/or web-based graphical user interfaces
    • …
    corecore